Global Immuno-oncology Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immuno-oncology Therapy market size was valued at US$ 1206.2 million in 2023. With growing demand in downstream market, the Immuno-oncology Therapy is forecast to a readjusted size of US$ 1660 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Immuno-oncology Therapy market. Immuno-oncology Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immuno-oncology Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immuno-oncology Therapy market.
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
Key Features:
The report on Immuno-oncology Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immuno-oncology Therapy market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Immune Checkpoint Inhibitors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immuno-oncology Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immuno-oncology Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immuno-oncology Therapy industry. This include advancements in Immuno-oncology Therapy technology, Immuno-oncology Therapy new entrants, Immuno-oncology Therapy new investment, and other innovations that are shaping the future of Immuno-oncology Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immuno-oncology Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Immuno-oncology Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immuno-oncology Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immuno-oncology Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immuno-oncology Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immuno-oncology Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immuno-oncology Therapy market.
Market Segmentation:
Immuno-oncology Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Immuno-oncology Therapy market size was valued at US$ 1206.2 million in 2023. With growing demand in downstream market, the Immuno-oncology Therapy is forecast to a readjusted size of US$ 1660 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Immuno-oncology Therapy market. Immuno-oncology Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immuno-oncology Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immuno-oncology Therapy market.
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
Key Features:
The report on Immuno-oncology Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immuno-oncology Therapy market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Immune Checkpoint Inhibitors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immuno-oncology Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immuno-oncology Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immuno-oncology Therapy industry. This include advancements in Immuno-oncology Therapy technology, Immuno-oncology Therapy new entrants, Immuno-oncology Therapy new investment, and other innovations that are shaping the future of Immuno-oncology Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immuno-oncology Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Immuno-oncology Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immuno-oncology Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immuno-oncology Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immuno-oncology Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immuno-oncology Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immuno-oncology Therapy market.
Market Segmentation:
Immuno-oncology Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- Immune System Modulators
- Cancer Vaccines
- Hospitals
- Ambulatory Surgical Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
- BioNTech SE
- Allogene Therapeutics
- IMAB-I-Mab Biopharma Co., Ltd.
- Arcus Biosciences
- Gritstone Oncology
- Autolus Therapeutics
- Rubius Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size 2019-2030
2.1.2 Immuno-oncology Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immuno-oncology Therapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immune Checkpoint Inhibitors
2.2.3 Immune System Modulators
2.2.4 Cancer Vaccines
2.3 Immuno-oncology Therapy Market Size by Type
2.3.1 Immuno-oncology Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
2.4 Immuno-oncology Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Center
2.4.3 Others
2.5 Immuno-oncology Therapy Market Size by Application
2.5.1 Immuno-oncology Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
3 IMMUNO-ONCOLOGY THERAPY MARKET SIZE BY PLAYER
3.1 Immuno-oncology Therapy Market Size Market Share by Players
3.1.1 Global Immuno-oncology Therapy Revenue by Players (2019-2024)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-oncology Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY THERAPY BY REGIONS
4.1 Immuno-oncology Therapy Market Size by Regions (2019-2024)
4.2 Americas Immuno-oncology Therapy Market Size Growth (2019-2024)
4.3 APAC Immuno-oncology Therapy Market Size Growth (2019-2024)
4.4 Europe Immuno-oncology Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Immuno-oncology Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immuno-oncology Therapy Market Size by Country (2019-2024)
5.2 Americas Immuno-oncology Therapy Market Size by Type (2019-2024)
5.3 Americas Immuno-oncology Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-oncology Therapy Market Size by Region (2019-2024)
6.2 APAC Immuno-oncology Therapy Market Size by Type (2019-2024)
6.3 APAC Immuno-oncology Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-oncology Therapy by Country (2019-2024)
7.2 Europe Immuno-oncology Therapy Market Size by Type (2019-2024)
7.3 Europe Immuno-oncology Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-oncology Therapy by Region (2019-2024)
8.2 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET FORECAST
10.1 Global Immuno-oncology Therapy Forecast by Regions (2025-2030)
10.1.1 Global Immuno-oncology Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Immuno-oncology Therapy Forecast
10.1.3 APAC Immuno-oncology Therapy Forecast
10.1.4 Europe Immuno-oncology Therapy Forecast
10.1.5 Middle East & Africa Immuno-oncology Therapy Forecast
10.2 Americas Immuno-oncology Therapy Forecast by Country (2025-2030)
10.2.1 United States Immuno-oncology Therapy Market Forecast
10.2.2 Canada Immuno-oncology Therapy Market Forecast
10.2.3 Mexico Immuno-oncology Therapy Market Forecast
10.2.4 Brazil Immuno-oncology Therapy Market Forecast
10.3 APAC Immuno-oncology Therapy Forecast by Region (2025-2030)
10.3.1 China Immuno-oncology Therapy Market Forecast
10.3.2 Japan Immuno-oncology Therapy Market Forecast
10.3.3 Korea Immuno-oncology Therapy Market Forecast
10.3.4 Southeast Asia Immuno-oncology Therapy Market Forecast
10.3.5 India Immuno-oncology Therapy Market Forecast
10.3.6 Australia Immuno-oncology Therapy Market Forecast
10.4 Europe Immuno-oncology Therapy Forecast by Country (2025-2030)
10.4.1 Germany Immuno-oncology Therapy Market Forecast
10.4.2 France Immuno-oncology Therapy Market Forecast
10.4.3 UK Immuno-oncology Therapy Market Forecast
10.4.4 Italy Immuno-oncology Therapy Market Forecast
10.4.5 Russia Immuno-oncology Therapy Market Forecast
10.5 Middle East & Africa Immuno-oncology Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Immuno-oncology Therapy Market Forecast
10.5.2 South Africa Immuno-oncology Therapy Market Forecast
10.5.3 Israel Immuno-oncology Therapy Market Forecast
10.5.4 Turkey Immuno-oncology Therapy Market Forecast
10.5.5 GCC Countries Immuno-oncology Therapy Market Forecast
10.6 Global Immuno-oncology Therapy Forecast by Type (2025-2030)
10.7 Global Immuno-oncology Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Immuno-oncology Therapy Product Offered
11.1.3 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Immuno-oncology Therapy Product Offered
11.2.3 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Offered
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Information
11.4.2 Eli-Lilly Immuno-oncology Therapy Product Offered
11.4.3 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli-Lilly Main Business Overview
11.4.5 Eli-Lilly Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Immuno-oncology Therapy Product Offered
11.5.3 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Offered
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Immuno-oncology Therapy Product Offered
11.7.3 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Immuno-oncology Therapy Product Offered
11.8.3 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Immuno-oncology Therapy Product Offered
11.9.3 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Immuno-oncology Therapy Product Offered
11.10.3 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Immuno-oncology Therapy Product Offered
11.11.3 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Information
11.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Spectrum Pharmaceuticals Main Business Overview
11.12.5 Spectrum Pharmaceuticals Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Immuno-oncology Therapy Product Offered
11.13.3 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
11.14 BioNTech SE
11.14.1 BioNTech SE Company Information
11.14.2 BioNTech SE Immuno-oncology Therapy Product Offered
11.14.3 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 BioNTech SE Main Business Overview
11.14.5 BioNTech SE Latest Developments
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Information
11.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Offered
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Allogene Therapeutics Main Business Overview
11.15.5 Allogene Therapeutics Latest Developments
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Information
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Main Business Overview
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Latest Developments
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Information
11.17.2 Arcus Biosciences Immuno-oncology Therapy Product Offered
11.17.3 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Arcus Biosciences Main Business Overview
11.17.5 Arcus Biosciences Latest Developments
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Information
11.18.2 Gritstone Oncology Immuno-oncology Therapy Product Offered
11.18.3 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gritstone Oncology Main Business Overview
11.18.5 Gritstone Oncology Latest Developments
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Information
11.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Offered
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Autolus Therapeutics Main Business Overview
11.19.5 Autolus Therapeutics Latest Developments
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Information
11.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Offered
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Rubius Therapeutics Main Business Overview
11.20.5 Rubius Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size 2019-2030
2.1.2 Immuno-oncology Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immuno-oncology Therapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immune Checkpoint Inhibitors
2.2.3 Immune System Modulators
2.2.4 Cancer Vaccines
2.3 Immuno-oncology Therapy Market Size by Type
2.3.1 Immuno-oncology Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
2.4 Immuno-oncology Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Center
2.4.3 Others
2.5 Immuno-oncology Therapy Market Size by Application
2.5.1 Immuno-oncology Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
3 IMMUNO-ONCOLOGY THERAPY MARKET SIZE BY PLAYER
3.1 Immuno-oncology Therapy Market Size Market Share by Players
3.1.1 Global Immuno-oncology Therapy Revenue by Players (2019-2024)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-oncology Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY THERAPY BY REGIONS
4.1 Immuno-oncology Therapy Market Size by Regions (2019-2024)
4.2 Americas Immuno-oncology Therapy Market Size Growth (2019-2024)
4.3 APAC Immuno-oncology Therapy Market Size Growth (2019-2024)
4.4 Europe Immuno-oncology Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Immuno-oncology Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immuno-oncology Therapy Market Size by Country (2019-2024)
5.2 Americas Immuno-oncology Therapy Market Size by Type (2019-2024)
5.3 Americas Immuno-oncology Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-oncology Therapy Market Size by Region (2019-2024)
6.2 APAC Immuno-oncology Therapy Market Size by Type (2019-2024)
6.3 APAC Immuno-oncology Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-oncology Therapy by Country (2019-2024)
7.2 Europe Immuno-oncology Therapy Market Size by Type (2019-2024)
7.3 Europe Immuno-oncology Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-oncology Therapy by Region (2019-2024)
8.2 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET FORECAST
10.1 Global Immuno-oncology Therapy Forecast by Regions (2025-2030)
10.1.1 Global Immuno-oncology Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Immuno-oncology Therapy Forecast
10.1.3 APAC Immuno-oncology Therapy Forecast
10.1.4 Europe Immuno-oncology Therapy Forecast
10.1.5 Middle East & Africa Immuno-oncology Therapy Forecast
10.2 Americas Immuno-oncology Therapy Forecast by Country (2025-2030)
10.2.1 United States Immuno-oncology Therapy Market Forecast
10.2.2 Canada Immuno-oncology Therapy Market Forecast
10.2.3 Mexico Immuno-oncology Therapy Market Forecast
10.2.4 Brazil Immuno-oncology Therapy Market Forecast
10.3 APAC Immuno-oncology Therapy Forecast by Region (2025-2030)
10.3.1 China Immuno-oncology Therapy Market Forecast
10.3.2 Japan Immuno-oncology Therapy Market Forecast
10.3.3 Korea Immuno-oncology Therapy Market Forecast
10.3.4 Southeast Asia Immuno-oncology Therapy Market Forecast
10.3.5 India Immuno-oncology Therapy Market Forecast
10.3.6 Australia Immuno-oncology Therapy Market Forecast
10.4 Europe Immuno-oncology Therapy Forecast by Country (2025-2030)
10.4.1 Germany Immuno-oncology Therapy Market Forecast
10.4.2 France Immuno-oncology Therapy Market Forecast
10.4.3 UK Immuno-oncology Therapy Market Forecast
10.4.4 Italy Immuno-oncology Therapy Market Forecast
10.4.5 Russia Immuno-oncology Therapy Market Forecast
10.5 Middle East & Africa Immuno-oncology Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Immuno-oncology Therapy Market Forecast
10.5.2 South Africa Immuno-oncology Therapy Market Forecast
10.5.3 Israel Immuno-oncology Therapy Market Forecast
10.5.4 Turkey Immuno-oncology Therapy Market Forecast
10.5.5 GCC Countries Immuno-oncology Therapy Market Forecast
10.6 Global Immuno-oncology Therapy Forecast by Type (2025-2030)
10.7 Global Immuno-oncology Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Immuno-oncology Therapy Product Offered
11.1.3 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Immuno-oncology Therapy Product Offered
11.2.3 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Offered
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Information
11.4.2 Eli-Lilly Immuno-oncology Therapy Product Offered
11.4.3 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli-Lilly Main Business Overview
11.4.5 Eli-Lilly Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Immuno-oncology Therapy Product Offered
11.5.3 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Offered
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Immuno-oncology Therapy Product Offered
11.7.3 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Immuno-oncology Therapy Product Offered
11.8.3 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Immuno-oncology Therapy Product Offered
11.9.3 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Immuno-oncology Therapy Product Offered
11.10.3 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Immuno-oncology Therapy Product Offered
11.11.3 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Information
11.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Spectrum Pharmaceuticals Main Business Overview
11.12.5 Spectrum Pharmaceuticals Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Immuno-oncology Therapy Product Offered
11.13.3 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
11.14 BioNTech SE
11.14.1 BioNTech SE Company Information
11.14.2 BioNTech SE Immuno-oncology Therapy Product Offered
11.14.3 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 BioNTech SE Main Business Overview
11.14.5 BioNTech SE Latest Developments
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Information
11.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Offered
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Allogene Therapeutics Main Business Overview
11.15.5 Allogene Therapeutics Latest Developments
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Information
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Main Business Overview
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Latest Developments
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Information
11.17.2 Arcus Biosciences Immuno-oncology Therapy Product Offered
11.17.3 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Arcus Biosciences Main Business Overview
11.17.5 Arcus Biosciences Latest Developments
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Information
11.18.2 Gritstone Oncology Immuno-oncology Therapy Product Offered
11.18.3 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Gritstone Oncology Main Business Overview
11.18.5 Gritstone Oncology Latest Developments
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Information
11.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Offered
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Autolus Therapeutics Main Business Overview
11.19.5 Autolus Therapeutics Latest Developments
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Information
11.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Offered
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Rubius Therapeutics Main Business Overview
11.20.5 Rubius Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immuno-oncology Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Immune System Modulators
Table 5. Major Players of Cancer Vaccines
Table 6. Immuno-oncology Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 9. Immuno-oncology Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Immuno-oncology Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Immuno-oncology Therapy Revenue Market Share by Player (2019-2024)
Table 14. Immuno-oncology Therapy Key Players Head office and Products Offered
Table 15. Immuno-oncology Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immuno-oncology Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Immuno-oncology Therapy Market Size Market Share by Regions (2019-2024)
Table 20. Global Immuno-oncology Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Immuno-oncology Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Immuno-oncology Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Immuno-oncology Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Immuno-oncology Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 32. APAC Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 34. Europe Immuno-oncology Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Immuno-oncology Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 38. Europe Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Immuno-oncology Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Immuno-oncology Therapy
Table 47. Key Market Challenges & Risks of Immuno-oncology Therapy
Table 48. Key Industry Trends of Immuno-oncology Therapy
Table 49. Global Immuno-oncology Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Immuno-oncology Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Immuno-oncology Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Amgen Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 54. Amgen Immuno-oncology Therapy Product Offered
Table 55. Amgen Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. AstraZeneca Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 59. AstraZeneca Immuno-oncology Therapy Product Offered
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. AstraZeneca Latest Developments
Table 63. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Immuno-oncology Therapy Product Offered
Table 65. Bristol-Myers Squibb Main Business
Table 66. Bristol-Myers Squibb Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Eli-Lilly Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 69. Eli-Lilly Immuno-oncology Therapy Product Offered
Table 70. Eli-Lilly Main Business
Table 71. Eli-Lilly Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Eli-Lilly Latest Developments
Table 73. Roche Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 74. Roche Immuno-oncology Therapy Product Offered
Table 75. Roche Main Business
Table 76. Roche Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Latest Developments
Table 78. GlaxoSmithKline Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 79. GlaxoSmithKline Immuno-oncology Therapy Product Offered
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GlaxoSmithKline Latest Developments
Table 83. Janssen Biotech Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 84. Janssen Biotech Immuno-oncology Therapy Product Offered
Table 85. Janssen Biotech Main Business
Table 86. Janssen Biotech Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Janssen Biotech Latest Developments
Table 88. Merck Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 89. Merck Immuno-oncology Therapy Product Offered
Table 90. Merck Main Business
Table 91. Merck Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Latest Developments
Table 93. Novartis Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 94. Novartis Immuno-oncology Therapy Product Offered
Table 95. Novartis Main Business
Table 96. Novartis Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novartis Latest Developments
Table 98. Pfizer Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 99. Pfizer Immuno-oncology Therapy Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Pfizer Latest Developments
Table 103. Sanofi Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 104. Sanofi Immuno-oncology Therapy Product Offered
Table 105. Sanofi Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Spectrum Pharmaceuticals Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 109. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered
Table 110. Spectrum Pharmaceuticals Main Business
Table 111. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Spectrum Pharmaceuticals Latest Developments
Table 113. Takeda Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 114. Takeda Immuno-oncology Therapy Product Offered
Table 115. Takeda Main Business
Table 116. Takeda Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Takeda Latest Developments
Table 118. BioNTech SE Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 119. BioNTech SE Immuno-oncology Therapy Product Offered
Table 120. BioNTech SE Main Business
Table 121. BioNTech SE Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. BioNTech SE Latest Developments
Table 123. Allogene Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 124. Allogene Therapeutics Immuno-oncology Therapy Product Offered
Table 125. Allogene Therapeutics Main Business
Table 126. Allogene Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Allogene Therapeutics Latest Developments
Table 128. IMAB-I-Mab Biopharma Co., Ltd. Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 129. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered
Table 130. IMAB-I-Mab Biopharma Co., Ltd. Main Business
Table 131. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. IMAB-I-Mab Biopharma Co., Ltd. Latest Developments
Table 133. Arcus Biosciences Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 134. Arcus Biosciences Immuno-oncology Therapy Product Offered
Table 135. Arcus Biosciences Main Business
Table 136. Arcus Biosciences Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Arcus Biosciences Latest Developments
Table 138. Gritstone Oncology Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 139. Gritstone Oncology Immuno-oncology Therapy Product Offered
Table 140. Gritstone Oncology Main Business
Table 141. Gritstone Oncology Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Gritstone Oncology Latest Developments
Table 143. Autolus Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 144. Autolus Therapeutics Immuno-oncology Therapy Product Offered
Table 145. Autolus Therapeutics Main Business
Table 146. Autolus Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Autolus Therapeutics Latest Developments
Table 148. Rubius Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 149. Rubius Therapeutics Immuno-oncology Therapy Product Offered
Table 150. Rubius Therapeutics Main Business
Table 151. Rubius Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Rubius Therapeutics Latest Developments
Table 1. Immuno-oncology Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Immune System Modulators
Table 5. Major Players of Cancer Vaccines
Table 6. Immuno-oncology Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 9. Immuno-oncology Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Immuno-oncology Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Immuno-oncology Therapy Revenue Market Share by Player (2019-2024)
Table 14. Immuno-oncology Therapy Key Players Head office and Products Offered
Table 15. Immuno-oncology Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immuno-oncology Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Immuno-oncology Therapy Market Size Market Share by Regions (2019-2024)
Table 20. Global Immuno-oncology Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Immuno-oncology Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Immuno-oncology Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Immuno-oncology Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Immuno-oncology Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 32. APAC Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 34. Europe Immuno-oncology Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Immuno-oncology Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 38. Europe Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Immuno-oncology Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Immuno-oncology Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Immuno-oncology Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Immuno-oncology Therapy
Table 47. Key Market Challenges & Risks of Immuno-oncology Therapy
Table 48. Key Industry Trends of Immuno-oncology Therapy
Table 49. Global Immuno-oncology Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Immuno-oncology Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Immuno-oncology Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Amgen Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 54. Amgen Immuno-oncology Therapy Product Offered
Table 55. Amgen Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. AstraZeneca Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 59. AstraZeneca Immuno-oncology Therapy Product Offered
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. AstraZeneca Latest Developments
Table 63. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 64. Bristol-Myers Squibb Immuno-oncology Therapy Product Offered
Table 65. Bristol-Myers Squibb Main Business
Table 66. Bristol-Myers Squibb Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bristol-Myers Squibb Latest Developments
Table 68. Eli-Lilly Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 69. Eli-Lilly Immuno-oncology Therapy Product Offered
Table 70. Eli-Lilly Main Business
Table 71. Eli-Lilly Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Eli-Lilly Latest Developments
Table 73. Roche Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 74. Roche Immuno-oncology Therapy Product Offered
Table 75. Roche Main Business
Table 76. Roche Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Latest Developments
Table 78. GlaxoSmithKline Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 79. GlaxoSmithKline Immuno-oncology Therapy Product Offered
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GlaxoSmithKline Latest Developments
Table 83. Janssen Biotech Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 84. Janssen Biotech Immuno-oncology Therapy Product Offered
Table 85. Janssen Biotech Main Business
Table 86. Janssen Biotech Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Janssen Biotech Latest Developments
Table 88. Merck Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 89. Merck Immuno-oncology Therapy Product Offered
Table 90. Merck Main Business
Table 91. Merck Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Latest Developments
Table 93. Novartis Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 94. Novartis Immuno-oncology Therapy Product Offered
Table 95. Novartis Main Business
Table 96. Novartis Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novartis Latest Developments
Table 98. Pfizer Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 99. Pfizer Immuno-oncology Therapy Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Pfizer Latest Developments
Table 103. Sanofi Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 104. Sanofi Immuno-oncology Therapy Product Offered
Table 105. Sanofi Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Spectrum Pharmaceuticals Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 109. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered
Table 110. Spectrum Pharmaceuticals Main Business
Table 111. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Spectrum Pharmaceuticals Latest Developments
Table 113. Takeda Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 114. Takeda Immuno-oncology Therapy Product Offered
Table 115. Takeda Main Business
Table 116. Takeda Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Takeda Latest Developments
Table 118. BioNTech SE Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 119. BioNTech SE Immuno-oncology Therapy Product Offered
Table 120. BioNTech SE Main Business
Table 121. BioNTech SE Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. BioNTech SE Latest Developments
Table 123. Allogene Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 124. Allogene Therapeutics Immuno-oncology Therapy Product Offered
Table 125. Allogene Therapeutics Main Business
Table 126. Allogene Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Allogene Therapeutics Latest Developments
Table 128. IMAB-I-Mab Biopharma Co., Ltd. Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 129. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered
Table 130. IMAB-I-Mab Biopharma Co., Ltd. Main Business
Table 131. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. IMAB-I-Mab Biopharma Co., Ltd. Latest Developments
Table 133. Arcus Biosciences Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 134. Arcus Biosciences Immuno-oncology Therapy Product Offered
Table 135. Arcus Biosciences Main Business
Table 136. Arcus Biosciences Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Arcus Biosciences Latest Developments
Table 138. Gritstone Oncology Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 139. Gritstone Oncology Immuno-oncology Therapy Product Offered
Table 140. Gritstone Oncology Main Business
Table 141. Gritstone Oncology Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Gritstone Oncology Latest Developments
Table 143. Autolus Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 144. Autolus Therapeutics Immuno-oncology Therapy Product Offered
Table 145. Autolus Therapeutics Main Business
Table 146. Autolus Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Autolus Therapeutics Latest Developments
Table 148. Rubius Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors
Table 149. Rubius Therapeutics Immuno-oncology Therapy Product Offered
Table 150. Rubius Therapeutics Main Business
Table 151. Rubius Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Rubius Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Immuno-oncology Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-oncology Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immuno-oncology Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immuno-oncology Therapy Sales Market Share by Country/Region (2023)
Figure 8. Immuno-oncology Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immuno-oncology Therapy Market Size Market Share by Type in 2023
Figure 10. Immuno-oncology Therapy in Hospitals
Figure 11. Global Immuno-oncology Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immuno-oncology Therapy in Ambulatory Surgical Center
Figure 13. Global Immuno-oncology Therapy Market: Ambulatory Surgical Center (2019-2024) & ($ Millions)
Figure 14. Immuno-oncology Therapy in Others
Figure 15. Global Immuno-oncology Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Immuno-oncology Therapy Market Size Market Share by Application in 2023
Figure 17. Global Immuno-oncology Therapy Revenue Market Share by Player in 2023
Figure 18. Global Immuno-oncology Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immuno-oncology Therapy Value Market Share by Country in 2023
Figure 24. United States Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immuno-oncology Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Immuno-oncology Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Immuno-oncology Therapy Market Size Market Share by Application in 2023
Figure 31. China Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immuno-oncology Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Immuno-oncology Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immuno-oncology Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Immuno-oncology Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-oncology Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immuno-oncology Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immuno-oncology Therapy Sales Market Share by Country/Region (2023)
Figure 8. Immuno-oncology Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immuno-oncology Therapy Market Size Market Share by Type in 2023
Figure 10. Immuno-oncology Therapy in Hospitals
Figure 11. Global Immuno-oncology Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immuno-oncology Therapy in Ambulatory Surgical Center
Figure 13. Global Immuno-oncology Therapy Market: Ambulatory Surgical Center (2019-2024) & ($ Millions)
Figure 14. Immuno-oncology Therapy in Others
Figure 15. Global Immuno-oncology Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Immuno-oncology Therapy Market Size Market Share by Application in 2023
Figure 17. Global Immuno-oncology Therapy Revenue Market Share by Player in 2023
Figure 18. Global Immuno-oncology Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immuno-oncology Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immuno-oncology Therapy Value Market Share by Country in 2023
Figure 24. United States Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immuno-oncology Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Immuno-oncology Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Immuno-oncology Therapy Market Size Market Share by Application in 2023
Figure 31. China Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immuno-oncology Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immuno-oncology Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immuno-oncology Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Immuno-oncology Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immuno-oncology Therapy Market Size Market Share Forecast by Application (2025-2030)
